China-Based Porton Fine Chemicals Opens Technology Center In Cranbury, New Jersey
10/05/2016
According to the firm, “this new venture will serve the US biopharmaceutical industry, offering drug development and cross-lifecycle research, development and manufacturing solutions from a strategic location convenient to East Coast and West Coast-based companies."
Company officials said they choose the location because it is conveniently located off the NJ Turnpike [I-95] near many of the world's largest pharmaceutical companies in New Jersey, and with easy flight access to the innovation hotbeds of Boston and California; PTC can be reached in 45 minutes by road from Newark International Airport.
Featuring state of the art assets and experienced process scientists, engineers, analysts and support staff, PTC aims to deliver innovative solutions and compelling value on complex synthetic routes, next-generation processes and assembly of specialized molecules, officials explained.
Today's pharmaceutical company pipelines are dominated by complex molecules, posing formidable synthesis, scale-up and containment challenges, company experts said. According to Dr. John Dillon, Senior Vice President of Porton Fine Chemicals and President of PortonUSA, ADCs exemplify a "Perfect Storm" of manufacturing difficulties: unstable APIs and toxic intermediates requiring high containment, complex analytics, purifications and parenteral requirements.
"We see high demand for this type of niche process development and manufacturing as companies seek innovative external manufacturing partners who can bring considerable experience to reliably execute such projects, many of which involve single batches representing >$1 million in value,” he said.
"Building on our excellent track record and feedback from our customers, PTC is a key element of our global strategy to offer advanced technologies, diversify our service offerings, and enhance our engagement with customers from close proximity, ultimately helping them more efficiently meet their drug development and commercialization goals. It will also complement our new Shuitu Technology Center [Chongqing, China] to be opened by end-2016," Drs. Andrew Xu, President/Co-Chairman of PFC and Raj Iyer, Chief Business Officer, PFC explained.
"Leveraging the critical mass of experienced process chemists in this region and integrating PTC's CRO capabilities with PFC's manufacturing expertise centered in a lower cost geography such as China will offer powerful end-to-end solutions and seamless supply chains to the biopharmaceutical community," according to Dr. Todd Nelson, Vice President, Porton USA and General Manager, PTC.
Project Announcements
PEAK Precision Manufacturing Plans Bowling Green, Kentucky, Operations
07/26/2024
Italy-Based Sipcam Agro USA Upgrades Wayne County, Mississippi, Operations
07/26/2024
Cleveland-Cliffs Plans Weirton, West Virginia, Operations
07/26/2024
IDEXX Laboratories Plans Wilson, North Carolina, Production Operations
07/26/2024
Germany-Based Ritz Instrument Transformers Plans Waynesboro, Georgia, Operations
07/26/2024
AirJoule Plans Newark-Wilmington, Delaware, Operations
07/26/2024
Most Read
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The CHIPS and Science Act will bring jobs back to the United States
Q2 2024
-
The Bring Your Own Energy (BYOE) Party Is Starting
Q2 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
How to Overcome NIMBYism in Data Centers
Q2 2024